King of Prussia, PA; June 05, 2014) — Theorem Clinical Research, a leading contract research organization, will demonstrate how its advanced visual analytics tools and techniques provide a faster understanding of complex clinical data during the Drug Information Association’s (DIA) 50th Annual Meeting, June 16-19 in San Diego.
Throughout DIA 2014, Theorem will show participants how to turn data into meaningful insight by offering demonstrations of its visual analytics tools. Members of Theorem’s leadership team will also be providing expertise and industry insights on a range of topics during scheduled presentations, including:
Monday, June 16
8:30 a.m.–10 a.m. — John Potthoff, Theorem president and CEO, joins the panel discussion, “Beyond Operational Excellence: A Survey on Sponsor Expectations of Preferred Business Partners.”
Wednesday, June 18
1:30–3 p.m. — Linda Zillman, Theorem senior project director and franchise manager of the medical device business unit, joins the panel discussion, “Unique Device Identification Rule, Medical Device Reporting Draft Guidance and Post-Marketing Clinical Research Reporting Requirements.”
Thursday, June 19
9–10:30 a.m. — Angelika Tillmann, Theorem vice president of global clinical quality assurance and compliance and general manager, Europe, chairs the session, “GCP Quality Agreements.”
“DIA is one of the best environments for engaging innovative thinking,” said Potthoff. “The Theorem team looks forward to sharing our ideas and showcasing how our advanced visual analytics tools can help drug and device development companies make more informed decisions even faster.”
Throughout the 2014 event, visitors to Theorem’s booth — Booth 1245 — can register for a chance to win Google Glass. Attendees can also request VIP tickets to Theorem’s private theater (BS6) to view a demonstration of its visual analytics tools.